|Articles|March 11, 2021
- Pharmaceutical Executive-03-01-2021
- Volume 41
- Issue 3
Pharmaceutical Executive, March 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive March 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
The Amazon Effect: A Data-Fueled Customer Experienceabout 5 years ago
Why ESG Performance Metrics Matterabout 5 years ago
Pharma and Biotech’s 2020 Full-Year Viewabout 5 years ago
Persevering for Patientsabout 5 years ago
Biopharma’s Reputation Gets a Well-Earned Shot in the Armabout 5 years ago
IP and Capitalabout 5 years ago
IP and COVID-19about 5 years ago
Pharma Steps Up for Public Health Inequitiesabout 5 years ago
FDA Relays Recent Achievements, Maps Plans for Progressabout 5 years ago
IP and CollaborationNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5